Form 8-K - Current report:
SEC Accession No. 0001437749-24-031805
Filing Date
2024-10-23
Accepted
2024-10-23 08:00:14
Documents
16
Period of Report
2024-10-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20241022_8k.htm   iXBRL 8-K 29175
2 EXHIBIT 99.1 ex_736211.htm EX-99.1 1100
7 ex991.jpg GRAPHIC 331322
  Complete submission text file 0001437749-24-031805.txt   636449

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20241023.xsd EX-101.SCH 3944
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20241023_def.xml EX-101.DEF 13522
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20241023_lab.xml EX-101.LAB 17827
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20241023_pre.xml EX-101.PRE 13499
18 EXTRACTED XBRL INSTANCE DOCUMENT clnn20241022_8k_htm.xml XML 4962
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 241387829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)